CORE
đșđŠÂ
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
18 research outputs found
IMvigor130: A randomized, phase III study evaluating first-line (1L) atezolizumab (atezo) as monotherapy and in combination with platinum-based chemotherapy (chemo) in patients (pts) with locally advanced or metastatic urothelial carcinoma (mUC).
Author
Galsky Matt D. Grande, Enrique Davis, Ian D. De Santis, Maria Arija, Jose Angel Arranz Kikuchi, Eiji Mecke, Almut and Thastrom, Ann Christine Bamias, Aristotelis
Publication venue
Publication date
01/01/2018
Field of study
No full text
Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens
Determining viability of circulating tumor cells (CTCs) as a predictive biomarker for response in patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with Radium 223 (Ra).
Author
Aranzazu Gonzalez del Alba
Begona Mellado
+11Â more
Claudia Aura
Cristina SuĂĄrez
Daniel Castellano
Joan Carles
Jose Angel Arranz Arija
Jose Jimenez
Jose Luis Perez-Gracia
Josep Puig
M Isabel SĂĄez
Maria Jose Mendez-Vidal
Rafael Morales
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Phase II study of second line pazopanib in patients with metastatic renal cell carcinoma (mRCC) previously treated with a tyrosine kinase inhibitor (TKI).
Author
Aranzazu Gonzalez del Alba
Emilio Esteban
+9Â more
Enrique Gallardo Diaz
Joaquim Bellmunt
Jose Angel Arranz Arija
Jose-Luis Gonzalez-Larriba
Juan Manuel SepĂșlveda
Marta Guix
Olatz Etxaniz
Pablo Maroto
Xavier Garcia del Muro
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Prospective assessment of circulating endothelial cells (CECs) as early markers of clear cell renal cell carcinoma (CCRCC) progression in first-line setting: The Circles study (SOGUG 2011-01).
Author
Aranzazu Gonzalez del Alba
Daniel Castellano
+11Â more
Emilio Esteban
Francisco Javier Garcia Del Muro
Jesus Garcia-Donas
Jose Angel Arranz Arija
Juan Antonio Virizuela
Laura Basterretxea
Luis Leon Mateos
Maria Jose Mendez
Miguel Angel Climent
Susana Hernando POLO
Victor Oyarvides
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract (TCCU) after failure to one cisplatin-based systemic therapy in clinical practice.
Author
Aranzazu Gonzalez del Alba
Belen Gonzalez-Grajera
+10Â more
Daniel E. Castellano
Enrique Grande
Iciar Garcia Carbonero
Isabel Chirivella
Javier Puente
Jose Angel Arranz Arija
M. Pilar Lopez Criado
Maria L. Villalobos
Nicolas Mohedano
Ovidio Fernandez Calvo
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Preliminary circulating tumour cell (CTC) analysis in phase II study of weekly cabazitaxel for "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel treatment (SOGUG-CABASEM trial).
Author
Begoña Mellado
Begoña Perez-Valderrama
+14Â more
Cristina Caballero
Daniel E. Castellano
Eva Fernandez Parra
Ignacio Duran
Jose Angel Arranz Arija
Laura Muinelo
Luis Leon Mateos
Maria Ochoa de Olza
MarĂa JosĂ© Juan Fita
Miguel Angel Climent Duran
Montserrat Domenech
Ovidio Fernandez Calvo
Susana Hernando Polo
Urbano Anido
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Randomized phase II study of abiraterone acetate (AA) maintenance in combination with docetaxel after disease progression to AA in metastatic castration resistant prostate cancer (mCRPC): Preliminary safety results of first line AA treatmentâABIDO-SOGUG Trial.
Author
Albert Font
Alfonso Gomez de Liaño
+15Â more
Alfredo Sanchez-Hernandez
Aranzazu Gonzalez del Alba
Begona Mellado
Carmen Santander
Daniel E. Castellano
Emilio Esteban
Enrique Grande
Ignacio Duran
Javier Cassinello
Javier Puente
Jose Angel Arranz Arija
M Isabel SĂĄez
Martin LĂĄzaro Quintela
MarĂa JosĂ© MĂ©ndez-Vidal
Miguel Angel Climent
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Prospective assessment of circulating endothelial cells (CECs) as markers of activity of first-line treatment in advanced clear cell renal cell carcinoma (CCRCC): The CIRCLES study (SOGUG 2011-01).
Author
Aranzazu Gonzalez del Alba
Daniel E. Castellano
+12Â more
Emilio Esteban
Francisco Javier Perez
JesĂșs GarcĂa-Donas
Jose Angel Arranz Arija
Juan Francisco Rodriguez-Moreno
Juan Virizuela Echaburu
Laura Basterrechea
Luis Leon Mateos
MarĂa JosĂ© MĂ©ndez-Vidal
Miguel Angel Climent Duran
Susana Hernando Polo
Xavier Garcia del Muro
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study.
Author
Alvaro Pinto
Angel Rodriguez Sanchez
+18Â more
Aranzazu Gonzalez del Alba
Begoña Perez-Valderrama
Constanza Maximiano Alonso
Daniel E. Castellano
Edelmira Velez De Mendizabal
Gustavo Rubio
Isabel Chirivella
Javier L. Puertas
Jose Angel Arranz Arija
Jose-Luis Gonzalez-Larriba
José Carlos Villa Guzman
Julio Jose Lambea- Sorrosal
Luis LeĂłn Mateos
Martin LĂĄzaro Quintela
MarĂa JosĂ© Juan Fita
Pablo Borrega
Raquel Luque
Rocio GarcĂa DomĂnguez
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Randomized phase II study of abiraterone acetate maintenance in combination with docetaxel after disease progression to abiraterone acetate in metastatic castration-resistant prostate cancer (mCRPC): ABIDO SOGUG trial.
Author
Albert Font
Alfredo Sanchez
+15Â more
Aranzazu Gonzalez del Alba
Begoña Mellado
Carmen Santander
Daniel E. Castellano
Emilio Esteban
Enrique Grande
Ignacio Duran
Javier Cassinello
Javier Puente
Jose Angel Arranz Arija
José Pablo Maroto Rey
M Isabel Saez
Martin LĂĄzaro Quintela
MarĂa JosĂ© MĂ©ndez-Vidal
Miguel Angel Climent
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
1
2